Starting technology for high-risk type 1 diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study tests a new approach to help people with type 1 diabetes who have high blood sugar (A1c above 8.5%) and are not on an insulin pump. It looks at whether using diabetes technology can improve your glucose control.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 1 diabetes.
- Your most recent blood sugar test (A1c) is above 8.5%.
- You do not use an insulin pump (you give yourself shots instead).
- You speak English or Spanish as your main language.
- You have health insurance.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a closed-loop insulin pump combined with education can help people with type 1 diabetes better recognize and avoid dangerously low blood sugar. It may be a good fit if you've had diabetes for a long time and have trouble sensing when your blood sugar drops.
This trial is testing a new automated insulin pump system that talks to your smartphone and lets the care team check on you from home. It helps people with type 1 diabetes better manage their blood sugar without extra trips to the clinic.
This trial helps children with type 1 diabetes get advanced diabetes technology, aiming to reduce gaps in access for families with fewer resources. It will check whether these tools are usable and helpful for diabetes care in children who meet the study needs.
This study tests a new automated insulin delivery (AID) system that connects your insulin pump to your glucose monitor to help keep your blood sugar in range. It is for both children and adults with type 1 diabetes who have not used an AID system before.
This trial tests a hybrid closed-loop system that automatically adjusts insulin delivery. It may help you manage your blood sugar more easily if you currently give yourself daily insulin shots.
This study tests a new automated insulin pump system (Omnipod) that adjusts insulin doses on its own throughout the day for people with type 2 diabetes. The goal is to see if it helps keep blood sugar levels more stable while reducing the burden of manual insulin management.
Hear when a new Diabetes Mellitus, Type 1 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.